Sunday, April 13, 2025

Technology | 2016.04.15

STEMCELL Technologies Signs Exclusive Agreement with the Institute of Molecular Biotechnology to Commercialize Cerebral Organoid Culture Systems

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has entered into an exclusive licensing agreement with the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences for the rights to develop products for cerebral organoid culture to serve the international research community. Cerebral organoids, or brain organoids, are three-dimensional multicellular structures that mimic brain tissue in vitro and represent a groundbreaking new way to model neurological

 

For more information, please visit
http://www.businesswire.com/news/home/20[...]-Agreement-Institute-Molecular

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News